CEL-SCI (NYSEAMERICAN: CVM) CFO lands new 2036 stock option grant

Rhea-AI Filing Summary

CEL SCI CORP Chief Financial Officer Patricia B. Prichep received a grant of stock options covering 225,000 shares of common stock. The options have an exercise price of $1.49 per share, a reported transaction price of $0.01 per option, and expire on August 13, 2036. They vest in three equal annual installments beginning one year after the grant date. Following this award, she holds 299,693 options in total.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider PRICHEP PATRICIA B

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Options F1	225,000	$0.01	$2K

Holdings After Transaction: Options — 299,693 shares (Direct)

Footnotes (1)

1. F1. The stock options vest in three (3) equal annual installments commencing one year after the grant date.

Key Figures

Options granted: 225,000 Transaction price per option: $0.01 Exercise price: $1.49 +3 more

6 metrics

Options granted 225,000 Number of stock options awarded to CFO Patricia B. Prichep

Transaction price per option $0.01 Reported transaction price per newly granted option

Exercise price $1.49 Per-share exercise price for the underlying common stock

Underlying shares 225,000 Number of common shares underlying the new option grant

Expiration date 2036-08-13 Expiration date of the newly granted options

Post-grant option holdings 299,693 Total options held by the CFO following this transaction

Key Terms

stock options, exercise price, underlying security, Grant, award, or other acquisition, +1 more

5 terms

stock options financial

"The stock options vest in three (3) equal annual installments"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

exercise price financial

"conversion_or_exercise_price": "1.4900""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

underlying security financial

"underlying_security_title": "Common Stock""

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

vest financial

"The stock options vest in three (3) equal annual installments"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

What did CVM CFO Patricia Prichep report on this Form 4?

CVM’s CFO Patricia B. Prichep reported receiving a grant of 225,000 stock options. The options relate to CEL SCI CORP common stock and represent an increase in her derivative-based compensation holdings.

What is the exercise price of the new CEL SCI (CVM) options granted to the CFO?

The new options granted to the CVM CFO carry an exercise price of $1.49 per share. This is the price at which she may purchase CEL SCI CORP common shares upon exercising the options before expiration.

When do Patricia Prichep’s new CVM stock options vest?

The stock options vest in three equal annual installments starting one year after the grant date. This means the award becomes exercisable gradually over three years, aligning the CFO’s incentives with longer-term company performance.

When do the newly granted CEL SCI (CVM) options to the CFO expire?

The options granted to the CVM CFO expire on August 13, 2036. She must exercise any vested portion on or before that date to acquire CEL SCI CORP common shares at the stated exercise price.

How many CEL SCI (CVM) options does the CFO hold after this grant?

After this award, the CFO holds a total of 299,693 stock options. This figure includes the newly granted 225,000 options and reflects her reported derivative position in CEL SCI CORP following the transaction.

What transaction price per option was reported for the new CVM grant?

The filing reports a transaction price of $0.01 per option for the 225,000 options. This figure applies to the derivative security itself and is separate from the $1.49 per-share exercise price for the underlying common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/17/2026 - 09:23 AM Accepted by SEC EDGAR 08/17/2026 - 09:23 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PRICHEP PATRICIA B

(Last) (First) (Middle)

8229 BOONE BLVD., SUITE 802

(Street)

VIENNA VIRGINIA 22182

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options	$1.49	08/14/2026		A		225,000		(1)	08/13/2036	Common Stock	225,000	$0.01	299,693	D

Explanation of Responses:

1. The stock options vest in three (3) equal annual installments commencing one year after the grant date.

	Patricia Prichep	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)